Walk through a pharmacy, supermarket or health-food shop and the word biotic seems to be everywhere. There are probiotics for digestion, prebiotics for the microbiome, synbiotics that combine the two and postbiotics that promise similar benefits without live bacteria. Online, the family grows even larger: psychobiotics, paraprobiotics, pharmabiotics and phytobiotics.
They sound as though they belong to one neat scientific system. They do not.
Some have internationally agreed definitions. Some are useful research terms that are not yet ready to guide everyday treatment. Others are loose labels that can make ordinary plant compounds sound newer and more precise than they really are.
That is the biotics dilemma.
The shared ending makes these substances sound closely related and equally proven. In reality, they differ in what they contain, how they work, how well they have been studied and how carefully they are regulated.
This article separates the established science from the attractive language.
First, what does “biotic” mean?
The ending comes from the Greek word bios, meaning life. Its presence in a product name does not prove that the product contains living organisms, improves the microbiome or has a clinically meaningful effect.
Confused by probiotics, prebiotics, synbiotics and postbiotics?
The easiest way to understand the main terms is this:
Antibiotics act against bacteria.
Probiotics are selected living microorganisms with a demonstrated health benefit.
Prebiotics are substances selectively used by microorganisms in the body in a way that produces a health benefit. Think of it as food for bacteria sort of thing.
Synbiotics bring live microorganisms and a selectively used substrate together.
Postbiotics contain deliberately inactivated microorganisms, their components, or both, and must still provide a health benefit.
That last requirement matters. A substance does not earn one of these scientific names simply because it contains bacteria, fibre or bacterial fragments. A health benefit has to be shown.
Antibiotics: essential medicines, not general microbiome treatments
We all heard of antibiotics.
Most of us took antibiotics some time or another in our lives.
Antibiotics are medicines used to prevent or treat bacterial infections. They may kill bacteria or stop them multiplying. They do not treat viral illnesses such as colds and influenza. This is why its useless taking antibiotics for Influenza unless there is a secondary infection involved.
Their usefulness is beyond dispute. Respiratory infections, skin infections, surgery, and the treatment of serious bacterial infections all depend on effective antibiotics. Yet every course also creates selection pressure.
The problem here? Its resistance.
The World Health Organization reported that about one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotic treatment in 2023. Misuse and overuse accelerate this problem.[1]
Antibiotics can also disturb the gut microbial community (the gut flora). The size and duration of that disturbance vary with the drug, dose, treatment length and the person taking it. This does not mean that a prescribed antibiotic should be avoided. It means that antibiotics should be used for a clear bacterial indication, at the correct dose and for the prescribed duration.
Evidence : Strong evidence for treating susceptible bacterial infections. Strong evidence that unnecessary or inappropriate use contributes to antimicrobial resistance. Antibiotic are essential treatment for infection.
Probiotics: the strain matters
An expert consensus panel defines probiotics as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host”.[2]
Each part of that definition has a job. The organisms must be alive when administered. The amount must be adequate. Most importantly, a health benefit must be demonstrated.
This is why “contains live cultures” does not automatically mean “probiotic”. A fermented food may contain living microbes but not a strain tested for a specific health outcome. Conversely, a probiotic supplement is not useful for every digestive complaint simply because it contains billions of organisms.
Probiotic effects are often strain-specific and outcome-specific. Evidence for one strain, dose and condition cannot automatically be transferred to another strain or to a mixed product. The label Lactobacillus alone is not enough. It is rather like identifying a medicine only as “a painkiller” while leaving out the actual drug and dose.
Where does the evidence look most useful?
One of the better studied uses is the prevention of antibiotic-associated diarrhoea. A 2021 BMJ Open systematic review and meta-analysis of 42 randomised trials involving 11,305 adults found that probiotics reduced the relative risk by 37 percent. The benefit was clearer in people whose underlying risk of diarrhoea was moderate or high, and higher probiotic doses appeared more effective.[3]
There is also evidence that certain strains or combinations may improve some symptoms of irritable bowel syndrome. The difficulty is inconsistency. Trials use different organisms, combinations, doses and outcomes. An extensive review of 66 randomised trials found that efficacy varied by product and outcome, making blanket claims about “probiotics for IBS” unreliable.[4]
Are probiotics always harmless?
Most healthy people tolerate commonly used probiotics well, although temporary gas or bloating can occur. Risk is different in premature infants, critically ill people, people with severely weakened immune systems, those with impaired intestinal barriers and some patients with central venous catheters. Cases of bloodstream infection caused by organisms found in probiotic products have been documented in intensive-care patients.[5]
Evidence verdict: Promising and sometimes clinically useful, but never a single uniform treatment class. Choose by the exact strain, dose, indication and evidence, not by the largest number of “billions” on the packet.
Prebiotics: food for selected microbes, but not every fibre qualifies
A prebiotic is “a substrate that is selectively utilized by host microorganisms conferring a health benefit”.[6]
In everyday language, prebiotics are often described as food for beneficial gut bacteria. That is a helpful starting point, but the scientific definition is stricter. The substance must be selectively used by microorganisms and that use must benefit the host.
Some fermentable fibres, including certain fructans and galacto-oligosaccharides, meet this definition. Other compounds may eventually qualify too. Not every fibre is a prebiotic, and a fibre can still be valuable without being one.
Prebiotics occur naturally in foods such as onions, garlic, leeks, legumes, whole grains and some fruit. You can read more about the benefits of legumes in my article here. Food sources also bring vitamins, minerals and other plant compounds, which is one reason a varied high-fibre diet is usually a more sensible foundation than chasing a single fashionable ingredient.
Prebiotic supplements can alter specific gut bacteria, but a change in a microbiome test is not the same as a health improvement that a person can feel or that reduces disease risk. Clinical results depend on the compound, dose, population and outcome. Fermentable products can also worsen gas, bloating or pain in some people, particularly those with irritable bowel syndrome.
Evidence: The biological basis is well established and certain prebiotics meet a recognised definition. Evidence for specific clinical benefits is variable. “Feeds good bacteria” is not enough on its own.
Combinations of prebiotics and probiotics for general gut health exist and you can find her from Amazon
Synbiotics: more than a probiotic and prebiotic placed in one box
A synbiotic is “a mixture comprising live microorganisms and substrate(s) selectively utilized by host microorganisms that confers a health benefit on the host”.[7]
There are two types.
A complementary synbiotic combines a probiotic and a prebiotic that each meet their own definition and can work independently.
A synergistic synbiotic is designed so that the chosen substrate is used by the co-administered microorganism. The components work together to produce the benefit.
Synbiotics have been studied in constipation, irritable bowel syndrome, metabolic disorders and other conditions. Some trials report benefit, but results remain difficult to compare because formulations differ widely. A positive trial for one combination cannot validate every synbiotic product.
Evidence verdict: A legitimate, consensus-defined category with plausible advantages. Clinical confidence still has to be built product by product and condition by condition.
Postbiotics: microbes do not have to be alive to have an effect
The agreed definition of a postbiotic is “a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host”.[8]
In plain English, the microorganisms have been deliberately inactivated, but the preparation may still interact with the immune system, gut barrier or microbial community. It can include microbial cells, cell fragments and metabolites that remain within the preparation.
Purified chemicals made by microbes, such as isolated butyrate, are not automatically postbiotics. Neither is any heat-killed bacterial powder. The preparation must be characterised and shown to provide a health benefit.
Postbiotics have practical appeal. Because the microbes are not alive, products may be more stable and may avoid some of the risks associated with administering living organisms. This does not make them automatically effective or risk-free.
Human evidence is growing but is much smaller than the evidence base for probiotics. A 2025 meta-analysis of randomised trials examining metabolic outcomes found some favourable changes, but the number and size of studies were limited and the preparations varied.[9] One well-designed trial in The Lancet Gastroenterology & Hepatology found that a heat-inactivated strain improved symptoms in people with irritable bowel syndrome, showing that a non-living preparation can have a clinical effect.[10] It does not prove that all postbiotics work for IBS.
Evidence : Scientifically credible and potentially useful, but still an emerging field. The word postbiotic should not be treated as a guarantee of benefit.
Psychobiotics: an exciting idea that has run ahead of clinical certainty
The term psychobiotic was first used for microorganisms that might benefit mental health through interactions between the gut and brain. It is now sometimes used more broadly for any microbiome-targeted intervention, including probiotics, prebiotics or dietary patterns, that produces a bacterially mediated effect on the brain.[11]
The gut and brain do communicate through neural, immune, endocrine and metabolic pathways. That part is not fiction. I talk about this topic in my article here. The harder question is whether a specific product produces a meaningful and reliable improvement in depression, anxiety, stress, sleep or cognition.
Meta-analyses have reported small improvements in some psychological outcomes, but studies are heterogeneous and often small. Different strains, doses, treatment periods and participant groups are pooled together. Publication bias and the use of self-reported outcomes add uncertainty. A psychobiotic should not replace established treatment for depression, anxiety or another mental health condition.
Evidence: A useful research concept, not a mature treatment category. Interesting enough to study, not strong enough to support sweeping claims.
Paraprobiotics: usually better understood within the postbiotic category
Paraprobiotic is commonly used for non-viable microbial cells, sometimes described as “ghost probiotics” or heat-killed probiotics. The term has no single universally accepted clinical definition.
Under the 2021 consensus framework, a preparation of inanimate microorganisms or their components that produces a demonstrated health benefit fits the definition of a postbiotic.[8] Using one consistent term reduces confusion.
Evidence : A term found in research and marketing, but often overlapping with postbiotics. Look for the preparation, trial and outcome rather than becoming attached to the label.
Phytobiotics: a plant-based label with an identity problem
Phyto means plant. Phytobiotics are generally described as plant-derived bioactive substances, including herbs, extracts, essential oils and phytochemicals, that may affect microbes or host health.
Unlike probiotics, prebiotics, synbiotics and postbiotics, there is no widely adopted human-health consensus definition. The term appears much more often in animal nutrition, where plant-derived feed additives are studied as possible alternatives to antibiotic growth promoters.[12]
For human health, it is usually clearer to name the actual compound or food: polyphenols, flavonoids, garlic, green tea, curcumin or a specific botanical extract. These substances have different chemistry, doses, absorption, benefits and risks. Grouping them as phytobiotics may create an impression of shared efficacy that has not been established.
Plants can certainly influence the microbiome. Polyphenol-rich foods and varied plant diets are important research areas. That does not validate every extract, essential oil or “microbiome-balancing” herbal blend. Concentrated botanical products can interact with medicines and may cause adverse effects.
Evidence : Biologically plausible but poorly standardised as a human therapeutic category. Ask what the plant substance actually is and what human trials support that exact product.
Pharmabiotics, next-generation probiotics and live biotherapeutic products
Pharmabiotic is an umbrella research term for microbiome-related interventions developed with a pharmaceutical purpose. It may include live organisms, microbial components or products derived from them. It is not a single standardised treatment category.
A more precise regulatory concept is the live biotherapeutic product: a biological product containing live organisms that is intended to prevent, treat or cure disease and is not a vaccine. These products are developed more like medicines than ordinary food supplements, with attention to identity, manufacturing, dose, safety and clinical efficacy.
“Next-generation probiotic” usually refers to newer microbial candidates identified through microbiome research rather than traditional food-associated strains. The phrase describes a development pathway, not proof that the organism is safer or more effective.
Evidence : Important areas of drug development. They should not be confused with an over-the-counter supplement that has not gone through medicine-level testing.
How to judge any “biotic” product
Ignore the front of the pack for a moment and ask six questions.
What exactly is in it? For a probiotic, look for the full strain designation, not only the genus or species. For a prebiotic, identify the substrate. For a plant product, identify the extract and dose.
What health outcome was tested? A change in bacterial abundance is not automatically a clinical benefit.
Was this exact product studied? Evidence for a neighbouring strain or ingredient is not interchangeable.
How large and reliable was the evidence? Give more weight to well-conducted randomised trials and systematic reviews than to laboratory studies, animal work or testimonials.
Who was studied? Results in healthy adults may not apply to children, pregnant women, frail older people or patients with serious illness.
What are the risks? Consider immune status, severe illness, allergies, medicine interactions, product quality and the possibility of delaying effective care.
Thanks for reading Evidence-based health! This post is public so feel free to share it.
The practical bottom line
The microbiome is important, but it is not a slot machine that pays out whenever another “biotic” is added.
Antibiotics remain indispensable when a bacterial infection requires them. Probiotics can be useful for selected conditions, but the strain and dose matter. Prebiotics can support microbial activity, yet not every fibre qualifies. Synbiotics and postbiotics have serious scientific definitions, although evidence still belongs to the exact preparation tested. Psychobiotics are promising but preliminary. Paraprobiotics overlap with postbiotics. Phytobiotics are so loosely defined in human health that the specific plant compound matters far more than the label.
The most honest answer is rarely “biotics work” or “biotics do not work”. It is: which one, in which formulation, for whom, for what outcome, and on the strength of what evidence?
That question is less exciting than the marketing. It is also much more useful.
Safety note
This article is for general knowledge only and does not replace individual medical advice. Speak to a doctor or pharmacist before using a live microbial product. Do not stop, start or shorten prescribed antibiotic treatment without advice from the prescriber.
Here are some useful links:
The healthy gut blueprint (40 minute mini-course)
References
1. World Health Organization. Antimicrobial resistance. WHO; updated 16 July 2026. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
2. Hill C, Guarner F, Reid G, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506-514. doi:10.1038/nrgastro.2014.66.
3. Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021;11:e043054. doi:10.1136/bmjopen-2020-043054.
4. McFarland LV, Karakan T, Karatas A. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;41:101154. doi:10.1016/j.eclinm.2021.101154.
5. Yelin I, Flett KB, Merakou C, et al. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 2019;25:1728-1732. doi:10.1038/s41591-019-0626-9.
6. Gibson GR, Hutkins R, Sanders ME, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491-502. doi:10.1038/nrgastro.2017.75.
7. Swanson KS, Gibson GR, Hutkins R, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17:687-701. doi:10.1038/s41575-020-0344-2.
8. Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18:649-667. doi:10.1038/s41575-021-00440-6.
9. Li S, Sohouli MH, Li Z. The effect of postbiotics supplementation on obesity and metabolic health: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab. 2025;22:140. doi:10.1186/s12986-025-01037-5.
10. Andresen V, Gschossmann J, Layer P. Heat-inactivated Bifidobacterium bifidum MIMBb75 in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterol Hepatol. 2020;5:658-666. doi:10.1016/S2468-1253(20)30056-X.
11. Berding K, Bastiaanssen TFS, Moloney GM, et al. Feed your microbes to deal with stress: a psychobiotic diet impacts microbial stability and perceived stress in a healthy adult population. Mol Psychiatry. 2023;28:601-610. doi:10.1038/s41380-022-01817-y.
12. Grashorn MA. Use of phytobiotics in broiler nutrition: an alternative to in-feed antibiotics? J Anim Feed Sci. 2010;19:338-347. doi:10.22358/jafs/66297/2010.
Editorial evidence note: Consensus definitions were used for probiotics, prebiotics, synbiotics and postbiotics. Claims about efficacy were kept indication-specific. Terms without a widely accepted human-health definition were labelled as emerging, overlapping or poorly standardised.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.